Replies to post #439510 on Anavex Life Sciences Corp (AVXL)

[crescentmotor]

Remember, the EMA was given all of the data from the P2b/3 study.

Although I had promised myself I would not add any more to my AVXL position without Rett EXCELLENCE trial success in hand, I nevertheless did add additional January 2025 calls today as I viewed today's PR as very encouraging for multiple reasons.